Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Teledermatology to support self-care in Chronic Spontaneous Uticaria
ABSTRACT
Chronic spontaneous urticaria (CSU) is an autoimmune prompted skin disorder whose hallmarks include the unpredictable onset of hives and itch.1,2 Symptom duration typically exceed 6 weeks, and flares can occur for up to 5 years or longer if untreated,3 impacting potentially any area of the body.4 The absence of obvious triggers and the variation in onset frequency often delays formal diagnosis which on average is ~ 2 years from first presentation.5 Initial standard of care is the use of low through to higher strength antihistamines in first instance, with eventual escalation to prescription anti-inflammatory agents and potentially biologics once patients are under managed care.6 The societal impacts of delays in diagnosis are marked, with data suggesting CSU impacts up to 1% of the population, primarily of working age and with twice the prevalence in women.5 Herein we advocate for the deployment of smartphone imaging and generative AI technology to improve detection and early management of CSU through integrated self-care approaches. Such approaches, embodying the tenets of P4 personalized medicine,7 could have sustained impact on the disease through awareness campaigns, reducing the burden on the dermatology community and facilitating earlier access to curative therapeutic interventions.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.